Vaidya Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 1.05 Cr
as on 15-12-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 Cr
as on 15-12-2024
- Revenue 62.86%
(FY 2015)
- Profit -84.45%
(FY 2015)
- Ebitda -21.63%
(FY 2015)
- Net Worth -44.21%
(FY 2015)
- Total Assets 23.37%
(FY 2015)
About Vaidya Life Sciences
The Corporate was formerly known as Vaidya Marketing Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.05 Cr.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Subash Gopalakrishnan and Sreeja Subash serve as directors at the Company.
- CIN/LLPIN
U51909KL2009PTC023760
- Company No.
023760
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2009
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vaidya Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subash Gopalakrishnan  | Managing Director | 28-Jan-2009 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreeja Subash | Director | 06-Sep-2016 | Current |
Financial Performance and Corporate Structure Insights of Vaidya Life Sciences.
Vaidya Life Sciences Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 62.86% increase. The company also saw a substantial fall in profitability, with a 84.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 44.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaidya Life Sciences?
In 2015, Vaidya Life Sciences had a promoter holding of 43.26% and a public holding of 56.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sree Rama Bio-Sciences Private LimitedActive 23 years 4 monthsSubash Gopalakrishnan and Sreeja Subash are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dhanlaxmi Bank Limited Creation Date: 04 Sep 2014 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Vaidya Life Sciences?
Unlock and access historical data on people associated with Vaidya Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaidya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaidya Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
